#4 - Unraveling the Complexities of Clinical Pharmacy in Heart Failure Management: A Discussion with Dr. Craig Beavers

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/95/bb/5c/95bb5c94-80e5-47d2-fb28-919fad379cba/mza_6306474668100189866.jpg/600x600bb.jpg

Action Potential

Slice of Healthcare

10 episodes

6 months ago

Unveiling the Future of Potassium Monitoring. Dive into the nexus of medical innovation and clinical expertise, as we spotlight the game-changers in healthcare and explore the transformative power of continuous potassium data. Join us on a journey of discovery, from the intricacies of hyperkalemia to the voices that shape the future of patient-centric care. Powered by ProtonIntel’s groundbreaking technology, we’re setting new standards and redefining the pulse of modern medicine.

All content for Action Potential is the property of Slice of Healthcare and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

#4 - Unraveling the Complexities of Clinical Pharmacy in Heart Failure Management: A Discussion with Dr. Craig Beavers

Action Potential

27 minutes

1 year ago

#4 - Unraveling the Complexities of Clinical Pharmacy in Heart Failure Management: A Discussion with Dr. Craig Beavers

Welcome back to Action Potential, join us this week as we welcome Dr. Craig Beavers, Associate Professor, UK College of Pharmacy

What you'll get from this episode:

The journey to becoming a clinical pharmacist.
Managing heart failure and cardio-oncology.
Navigating polypharmacy challenges in patient care.
The evolving role of clinical pharmacists in healthcare.
The importance of patient-focused care and medication management.
Future advancements in clinical pharmacy and patient monitoring.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Craig Beavers: https://www.linkedin.com/in/craig-beavers-pharmd-facc-faha-fccp-bccp-cacp-420b0a68/
And for more on UK College of Pharmacy: https://pharmacy.uky.edu/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/